Jerry C. Griffin - 12 Jun 2023 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Director
Signature
/s/ Bryan Phillips, as Attorney-in-Fact for Jerry C. Griffin
Issuer symbol
INSP
Transactions as of
12 Jun 2023
Net transactions value
-$147,477
Form type
4
Filing time
14 Jun 2023, 17:56:34 UTC
Previous filing
07 Jun 2023
Next filing
22 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $16,000 +1,000 +20% $16.00 6,084 12 Jun 2023 Direct
transaction INSP Common Stock Sale $8,962 -29 -0.48% $309.03 6,055 12 Jun 2023 Direct F1
transaction INSP Common Stock Sale $154,515 -500 -8.3% $309.03 5,555 12 Jun 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -1,000 -8.1% $0.000000 11,296 12 Jun 2023 Common Stock 1,000 $16.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F3 The option is fully vested and exercisable.